MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
26.98
-0.34
-1.24%
After Hours: 26.57 -0.41 -1.52% 17:22 12/31 EST
OPEN
27.27
PREV CLOSE
27.32
HIGH
27.40
LOW
26.69
VOLUME
1.59M
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
22.86
MARKET CAP
7.61B
P/E (TTM)
-12.1789
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CAI last week (1222-1226)?
Weekly Report · 12/29/2025 09:50
Caris Life Sciences: Stronger Fundamentals, Same Conclusion
Seeking Alpha · 12/24/2025 13:00
Caris Life Sciences Is Maintained at Hold by Canaccord Genuity
Dow Jones · 12/22/2025 12:54
Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30
Benzinga · 12/22/2025 12:45
Caris Life Sciences price target raised to $30 from $28 at Canaccord
TipRanks · 12/22/2025 11:55
Cathie Wood's weekly recap: boots bets on AI biotech, crypto; pares back consumer names
Seeking Alpha · 12/22/2025 11:30
Weekly Report: what happened at CAI last week (1215-1219)?
Weekly Report · 12/22/2025 09:50
Providence Swedish Cancer Institute Joins Caris Precision Oncology Alliance
Reuters · 12/19/2025 13:30
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.